Published on in Vol 23, No 3 (2021): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/26799, first published .
Minimizing the Impact of the COVID-19 Epidemic on Oncology Clinical Trials: Retrospective Study of Beijing Cancer Hospital

Minimizing the Impact of the COVID-19 Epidemic on Oncology Clinical Trials: Retrospective Study of Beijing Cancer Hospital

Minimizing the Impact of the COVID-19 Epidemic on Oncology Clinical Trials: Retrospective Study of Beijing Cancer Hospital

Authors of this article:

Zhiying Fu1 Author Orcid Image ;   Min Jiang1 Author Orcid Image ;   Kun Wang1 Author Orcid Image ;   Jian Li1 Author Orcid Image

Journals

  1. Huret L, Stoeklé H, Benmaziane A, Beuzeboc P, Hervé C. Cancer and COVID-19: ethical issues concerning the use of telemedicine during the pandemic. BMC Health Services Research 2022;22(1) View
  2. Meghiref Y, Parnot C, Duverger C, Difoum F, Gourden A, Yssaad H, Leiterer C, Bedekovic C, Blanchard J, Nait Ammar H, Schernberg A, Vanquaethem H, Helissey C. The Use of Telemedicine in Cancer Clinical Trials: Connect-Patient-to-Doctor Prospective Study. JMIR Cancer 2022;8(1):e31255 View
  3. Audisio K, Lia H, Robinson N, Rahouma M, Soletti G, Cancelli G, Perezgrovas Olaria R, Chadow D, Tam D, Vervoort D, Farkouh M, Bhatt D, Fremes S, Gaudino M. Impact of the COVID-19 Pandemic on Non-COVID-19 Clinical Trials. Journal of Cardiovascular Development and Disease 2022;9(1):19 View
  4. Fu Z, Liu X, Zhao S, Yuan Y, Jiang M. Reducing Clinical Trial Monitoring Resources and Costs With Remote Monitoring: Retrospective Study Comparing On-Site Versus Hybrid Monitoring. Journal of Medical Internet Research 2023;25:e42175 View
  5. Ye J, He L, Beestrum M. Implications for implementation and adoption of telehealth in developing countries: a systematic review of China’s practices and experiences. npj Digital Medicine 2023;6(1) View